In the Basque Country, a project has been created to investigate gene therapy, which for the first time will try to cure our disease systemically. The gene therapy research project, initially promoted by Sendabide, is being developed between several research centers in the territory of Vasconia or Euskal Herria. All the financial resources that Sendabide obtains are used to finance this research. We have signed a financing agreement for the years 2024, 2025 and 2026 with CIC-Biogune of Biscay, CIMA of Navarre and the Spanish VHL Alliance.


··· Video of the research project ···

··· Project features ···

It is an interdisciplinary and interinstitutional project. This is a project designed and promoted jointly by people from different health institutions and research centers in the Basque Country who formed a group together with Sendabide.

The people involved in the project belong to CIC-Biogune of Biscay, CIMA of Navarre, BioDonostia, EHU/UPV, Oncology Hospital of San Sebastian and Sendabide.

An advisory board has been created with globally outsanding people in VHL research and gene therapy, and the project was initiated after trustworthy contrast over its approach and feasibility.

··· How is the project going? ···

    In 2022 and 2023 the first phase has been developed: the production of viral vectors. This work has been carried out mainly at the CIMA center, in collaboration with CIC-Biogune. In 2024, the second phase has been undertaken, starting trials of viral vectors in cells and models. The second phase will be fully assumed by the CIC-Biogune by hiring a postdoctoral researcher for this purpose. It is a three-year phase that includes the years 2024, 2025 and 2026.